RL vs SGMO · P/E 24, rev $8.11B vs rev $57.8M
Ralph Lauren Corp Class A (RL) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
RL currently screens at market cap $16.95B and trailing P/E 24.1. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the RL and SGMO stock pages for the full models.
Not investment advice.